this should be easier to confirm studies this medicine dosage and time frame was developed with cdc infectious disease control and few xxx on site during development.
The studies should be familiar. Pending authorization about 10 to 14bdays moderna should be given clearance by Dec 21st...
Astra zeneca is next.
And Johnson Johnson shortly after conclusion of there one dose treatment around the new year.
Two others have entered phase three studies and both habe promising results.
0
To remove first post, remove entire topic.
this should be easier to confirm studies this medicine dosage and time frame was developed with cdc infectious disease control and few xxx on site during development.
The studies should be familiar. Pending authorization about 10 to 14bdays moderna should be given clearance by Dec 21st...
Astra zeneca is next.
And Johnson Johnson shortly after conclusion of there one dose treatment around the new year.
Two others have entered phase three studies and both habe promising results.
Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection — ramping up the race to begin limited vaccinations as the coronavirus rampage worsens.
Multiple vaccine candidates must succeed for the world to stamp out the pandemic, which has been on the upswing in the U.S. and Europe. U.S. hospitals have been stretched to the limit as the nation has seen more than 160,000 new cases per day and more than 1,400 daily deaths. Since first emerging nearly a year ago in China, the virus has killed more than 1.4 million people worldwide.
Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection — ramping up the race to begin limited vaccinations as the coronavirus rampage worsens.
Multiple vaccine candidates must succeed for the world to stamp out the pandemic, which has been on the upswing in the U.S. and Europe. U.S. hospitals have been stretched to the limit as the nation has seen more than 160,000 new cases per day and more than 1,400 daily deaths. Since first emerging nearly a year ago in China, the virus has killed more than 1.4 million people worldwide.
Moderna is one of several companies to have already submitted partial data to a "rolling review" process offered by Health Canada. Rather than presenting regulators with a complete package of trial results, the would-be vaccine-makers file data and findings as they become available. Canada has been looking at Moderna's first results since mid-October.
Canada has a different approval process than the United States and European countries, meaning that Moderna and Pfizer do not have to apply or reapply at each step. Instead, they have to submit their newest data and findings.
Moderna is one of several companies to have already submitted partial data to a "rolling review" process offered by Health Canada. Rather than presenting regulators with a complete package of trial results, the would-be vaccine-makers file data and findings as they become available. Canada has been looking at Moderna's first results since mid-October.
Canada has a different approval process than the United States and European countries, meaning that Moderna and Pfizer do not have to apply or reapply at each step. Instead, they have to submit their newest data and findings.
the first preliminary data from the trial, followed by the complete data on Nov. 30. Out of 196 cases of Covid-19 among trial volunteers, 185 were in people who received the placebo. And of the 11 vaccinated volunteers who got Covid-19, none suffered from severe disease. The researchers estimated that the vaccine had an efficy of 94.1 percent, far higher than experts had expected when vaccine testing began.
On Aug. 11, the United States government awarded the company an additional $1.5 billion in exchange for 100 million doses if the vaccine proves safe and effective. On Nov. 25, the company reached an agreement with the European Commission to supply up to 160 million doses Moderna has made similar deals with Canada Japan, and Qatar.
the first preliminary data from the trial, followed by the complete data on Nov. 30. Out of 196 cases of Covid-19 among trial volunteers, 185 were in people who received the placebo. And of the 11 vaccinated volunteers who got Covid-19, none suffered from severe disease. The researchers estimated that the vaccine had an efficy of 94.1 percent, far higher than experts had expected when vaccine testing began.
On Aug. 11, the United States government awarded the company an additional $1.5 billion in exchange for 100 million doses if the vaccine proves safe and effective. On Nov. 25, the company reached an agreement with the European Commission to supply up to 160 million doses Moderna has made similar deals with Canada Japan, and Qatar.
If you choose to make use of any information on this website including online sports betting services from any websites that may be featured on
this website, we strongly recommend that you carefully check your local laws before doing so.It is your sole responsibility to understand your local laws and observe them strictly.Covers does not provide
any advice or guidance as to the legality of online sports betting or other online gambling activities within your jurisdiction and you are responsible for complying with laws that are applicable to you in
your relevant locality.Covers disclaims all liability associated with your use of this website and use of any information contained on it.As a condition of using this website, you agree to hold the owner
of this website harmless from any claims arising from your use of any services on any third party website that may be featured by Covers.
Hot Forum Topics
